Table 1

Baseline characteristics

ParametermiLOOP+phaco
n=53
Control phaco
n=48
Age (years)70.2±10.367.7±9.9
Range45‒8738‒87
Gender, female, n (%)29 (55)21 (44)
Cataract grade3.55±0.503.58±0.50
Ocular comorbidities, n (%)
 Glaucoma16 (30)8 (17)
 Significant myopia2 (4)1 (2)
 Other*4 (8)4 (8)
Axial length (mm)23.73±0.9623.56±0.95
Range21.52‒27.8822.04‒25.81
Endothelial cell density (cells/mm2)2592±2202650±189
Range2066‒30002151‒2950
Central corneal thickness (µm)542±45553±39
Range451‒648464‒651
Baseline BCVA, decimal0.056±0.090.050±0.1
(Snellen equivalent)(20/360)(20/400)
  • *Other ocular comorbidities include ocular hypertension (n=4), and one each of diabetic retinopathy, traumatic glaucoma, pterygium nasal and ptosis. Values are presented as mean±SD unless otherwise indicated. Percentage values are rounded to the nearest integer.

  • BCVA, best corrected visual acuity; miLOOP, microinterventional loop prefragmentation.